{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:41:26Z","timestamp":1759455686639,"version":"build-2065373602"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2000,9,1]],"date-time":"2000-09-01T00:00:00Z","timestamp":967766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2000,9,1]],"date-time":"2000-09-01T00:00:00Z","timestamp":967766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2000,9]]},"DOI":"10.1053\/ajkd.2000.9682","type":"journal-article","created":{"date-parts":[[2008,3,20]],"date-time":"2008-03-20T21:11:45Z","timestamp":1206047505000},"page":"S18-S23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"S1","title":["Impact of angiotensin II on the kidney: Does an angiotensin II receptor blocker make sense?"],"prefix":"10.1053","volume":"36","author":[{"given":"Norman K.","family":"Hollenberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/ajkd.2000.9682_bib1","first-page":"39","volume":"22","year":"1980","journal-title":"Med Lett Drugs Ther"},{"key":"10.1053\/ajkd.2000.9682_bib2","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1001\/archinte.1997.00440420033005","article-title":"The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure","volume":"157","author":"Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1053\/ajkd.2000.9682_bib3","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJM197906213002505","article-title":"Reversal of vascular and renal crises of scleroderma by oral angiotensin-converting-enzyme blockade","volume":"300","author":"Lopez-Ovejero","year":"1979","journal-title":"N Engl J Med"},{"key":"10.1053\/ajkd.2000.9682_bib4","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1056\/NEJM198512263132601","article-title":"Effect of captopril on heavy proteinuria in azotemic diabetics","volume":"313","author":"Taguma","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1053\/ajkd.2000.9682_bib5","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1056\/NEJM198608213150813","article-title":"Effects of captopril on diabetic proteinuria","volume":"315","author":"O\u2019Hare","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1053\/ajkd.2000.9682_bib6","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1001\/jama.1980.03310040028020","article-title":"Proteinuria during long-term captopril therapy","volume":"244","author":"Case","year":"1980","journal-title":"JAMA"},{"issue":"suppl 3C","key":"10.1053\/ajkd.2000.9682_bib7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0002-9343(85)90078-6","article-title":"Therapeutic implications of hypertension-induced glomerular injury. Comparison of enalapril and a combination of hydralazine, reserpine, and hydrochlorothiazide in an experimental model","volume":"79","author":"Raij","year":"1985","journal-title":"Am J Med"},{"issue":"suppl 10","key":"10.1053\/ajkd.2000.9682_bib8","doi-asserted-by":"crossref","first-page":"S167","DOI":"10.1097\/00005344-198710100-00057","article-title":"Disparate effects of angiotensin converting enzyme inhibitor and calcium blocker treatment on the preservation of renal structure and function following subtotal nephrectomy or streptozotocin-induced diabetes in the rat","volume":"10","author":"Jackson","year":"1987","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1053\/ajkd.2000.9682_bib9","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/ki.1989.227","article-title":"Short and long term effects of antihypertensive therapy in the diabetic rat","volume":"36","author":"Anderson","year":"1989","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2000.9682_bib10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.7326\/0003-4819-118-2-199301150-00009","article-title":"Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis","volume":"118","author":"Kasiske","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1053\/ajkd.2000.9682_bib11","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","article-title":"The effect of angiotensin-converting\u2013enzyme inhibition on diabetic nephropathy","volume":"329","author":"Lewis","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1053\/ajkd.2000.9682_bib12","doi-asserted-by":"crossref","first-page":"577","DOI":"10.7326\/0003-4819-118-8-199304150-00001","article-title":"Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients","volume":"118","author":"Ravid","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1053\/ajkd.2000.9682_bib13","first-page":"127","article-title":"Protocol for prospective collaborative overviews of major randomized trials of blood-pressure-lowering treatments","volume":"16","year":"1998","journal-title":"J Hypertens"},{"issue":"suppl 11","key":"10.1053\/ajkd.2000.9682_bib14","first-page":"S239","article-title":"Pharmacologic interruption of the renin-angiotensin system and the kidney: Differential responses to angiotensin-converting enzyme and renin inhibition","volume":"10","author":"Hollenberg","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/ajkd.2000.9682_bib15","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/00004872-198406000-00010","article-title":"Evidence for a putatively new angiotensin II-generating enzyme in the vascular wall","volume":"2","author":"Okunishi","year":"1984","journal-title":"J Hypertens"},{"key":"10.1053\/ajkd.2000.9682_bib16","first-page":"207","article-title":"Marked species-difference in the vascular angiotensin II-forming pathways: humans versus rodents","volume":"62","author":"Okunishi","year":"1993","journal-title":"Jpn J Pharmacol"},{"key":"10.1053\/ajkd.2000.9682_bib17","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/0006-291X(87)90533-X","article-title":"Different distribution of two types of angiotensin II-generating enzymes in the aortic wall","volume":"149","author":"Okunishi","year":"1987","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1053\/ajkd.2000.9682_bib18","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1161\/01.RES.66.4.883","article-title":"Angiotensin II\u2013forming pathways in normal and failing human hearts","volume":"66","author":"Urata","year":"1990","journal-title":"Circ Res"},{"key":"10.1053\/ajkd.2000.9682_bib19","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1600-0773.1998.tb01572.x","article-title":"Does blockade of angiotensin II receptors offer clinical benefits over inhibition of angiotensin-converting enzyme?","volume":"82","author":"de Gasparo","year":"1998","journal-title":"Pharmacol Toxicol"},{"key":"10.1053\/ajkd.2000.9682_bib20","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.2337\/diacare.46.10.1612","article-title":"Role of angiotensin II and bradykinin in experimental diabetic nephropathy. Functional and structural studies","volume":"46","author":"Allen","year":"1997","journal-title":"Diabetes"},{"key":"10.1053\/ajkd.2000.9682_bib21","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0011-393X(99)90003-6","article-title":"The effects of valsartan and captopril on reducing microalbuminuria in patients with type 2 diabetes mellitus: A placebo-controlled trial","volume":"60","author":"Muirhead","year":"1999","journal-title":"Curr Ther Res"},{"key":"10.1053\/ajkd.2000.9682_bib22","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0140-6736(97)01187-2","article-title":"Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)","volume":"349","author":"Pitt","year":"1997","journal-title":"Lancet"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638600351071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638600351071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:18:51Z","timestamp":1759454331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638600351071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,9]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,9]]}},"alternative-id":["S0272638600351071"],"URL":"https:\/\/doi.org\/10.1053\/ajkd.2000.9682","relation":{},"ISSN":["0272-6386"],"issn-type":[{"type":"print","value":"0272-6386"}],"subject":[],"published":{"date-parts":[[2000,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of angiotensin II on the kidney: Does an angiotensin II receptor blocker make sense?","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/ajkd.2000.9682","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2000 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}